Inhibition of cdk2 Activating Phosphorylation by Mevastatin
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (7), 4840-4846
- https://doi.org/10.1074/jbc.m208658200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Proteasome Inhibitors Alter the Orderly Progression of DNA Synthesis during S-Phase in HeLa Cells and Lead to Rereplication of DNAExperimental Cell Research, 2000
- Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53Oncogene, 1998
- Results of intensive long-term treatment of familial hypercholesterolemiaThe American Journal of Cardiology, 1996
- Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21Nature, 1996
- A 39 Amino Acid Fragment of the Cell Cycle Regulator p21 Is Sufficient to Bind PCNA and Partially Inhibit DNA Replication in vivoNucleic Acids Research, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Principles of CDK regulationNature, 1995
- The function(s) of CAK, the p34cdc2-activating kinaseTrends in Biochemical Sciences, 1994
- Mammalian G1 cyclinsCell, 1993
- cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2Cell, 1991